Frings A, Steinberg J, Linke S J, Druchkiv V, Katz T
Univ.-Klinik für Augenheilkunde, Universitätsklinik Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Deutschland.
Care Vision GmbH, Hamburg, Deutschland.
Ophthalmologe. 2017 Aug;114(8):722-727. doi: 10.1007/s00347-016-0401-y.
Refractive lens exchange and implantation of a multifocal intraocular lens (MIOL) is mainly advised for ametropes with presbyopia. Non-presbyopic young ametropes who wish spectacle-independence are usually treated with corneal refractive surgery or phakic lenses.
This retrospective case series aimed to analyse the refractive and subjective satisfaction outcome after MIOL surgery in both eyes of non-presbyopic ametropes where other treatment options were not possible.
This retrospective case series comprised consecutively treated 32 eyes of 16 patients (5 myopic, 11 hyperopic patients; mean age 31 ± 6 years) who wished spectacle-independence and thus received an aspheric bifocal biconvex refractive-diffractive single-piece MIOL (Acri.Lisa 366/809, Carl Zeiss Meditec AG). Refractive data prior to and after surgery as well as subjective satisfaction at the 1‑year follow-up examination were assessed.
Related to distance corrected near visual acuity myopic eyes had a median efficacy index (EI) of 0.92 (±0.20) and hyperopes of 0.91 (±0.12) (P = 0.415). For intermediate vision, in both groups a lower EI (<0.5; P = 0.188) resulted in lower subjective satisfaction, which was higher for near and distance vision. Some of hyperopic patients reported limitations in near and distance vision, only one hyperopic patient would not have chosen this surgery again. None had a related complication during the follow-up.
When neither laser refractive surgery nor implantation of a phakic lens is possible, young non-presbyopic ametropes do profit from MIOL surgery with an aspheric bifocal biconvex refractive-diffractive MIOL.
屈光性晶状体置换术及植入多焦点人工晶状体(MIOL)主要适用于患有老花眼的屈光不正患者。希望摆脱眼镜的非老花眼年轻屈光不正患者通常接受角膜屈光手术或有晶状体眼人工晶状体治疗。
本回顾性病例系列旨在分析在无法采用其他治疗方案的非老花眼屈光不正患者双眼行MIOL手术后的屈光及主观满意度结果。
本回顾性病例系列纳入了16例患者(5例近视患者、11例远视患者;平均年龄31±6岁)连续接受治疗的32只眼,这些患者希望摆脱眼镜,因此接受了非球面双焦点双凸屈光 - 衍射一体式MIOL(Acri.Lisa 366/809,卡尔蔡司医疗技术股份公司)。评估了手术前后的屈光数据以及1年随访检查时的主观满意度。
就矫正近视力的远距离视力而言,近视眼中位疗效指数(EI)为0.92(±0.20),远视眼中位疗效指数为0.91(±0.12)(P = 0.415)。对于中间视力,两组较低的EI(<0.5;P = 0.188)导致主观满意度较低,而近视力和远距离视力的主观满意度较高。一些远视患者报告了近视力和远距离视力的限制,只有1例远视患者不会再次选择这种手术。随访期间均无相关并发症。
当激光屈光手术和有晶状体眼人工晶状体植入均不可行时,年轻的非老花眼屈光不正患者确实可从采用非球面双焦点双凸屈光 - 衍射MIOL的MIOL手术中获益。